S10 Ep50: Park and Grivas Expand on Treatment Updates in Bladder Cancer

from OncLive® On Air · host OncLive® On Air

Drs Park and Grivas discuss bladder cancer treatment updates, including results from the SunRISe-1 trial of TAR-200 plus cetrelimab in NMIBC.

Episode metadata supplied by the publisher feed · Published Aug 7, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep50: Park and Grivas Expand on Treatment Updates in Bladder Cancer

0:00 16:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 16 minutes long.

This episode was published on August 7, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!